Publications Office of the EU
Aufhebung des Open-House-Verfahrens Arzneimittelrabattverträge Tolvaptan (ATC-Code: C03XA01) - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Aufhebung des Open-House-Verfahrens Arzneimittelrabattverträge Tolvaptan (ATC-Code: C03XA01)

  • Today
    21/06/2025
Status
Submission closed
Type of contract
Supplies
Subject for Renewal
No
Buyer
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: DEB3D Donnersbergkreis
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Tender reference number
AOK24040-991
Description

Das Open-House-Verfahren Arzneimittelrabattverträge Tolvaptan (ATC-Code: C03XA01) wird mit Wirkung zum 31.05.2025 aufgehoben. Die bestehenden Verträge werden zu diesem Zeitpunkt gekündigt. Der Abschluss neuer Verträge ist im Rahmen dieses Open-House-Verfahrens nicht mehr möglich.

Submission Method
Not available
Tenders may be submitted
Not available
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Award method
unpublished
Estimated value
Not available
Final contracted value
Not available
Award of contract
Not available
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.